PLUS THERAPEUTICS, INC. (PSTV) Technical Analysis

🔺 Technical Setup

🎯 Decision Map

From a roadmap perspective, the setup is boxed by support near 6.38 and resistance around 8.28. A cleaner push through resistance would improve continuation odds, while a loss of support would weaken the current thesis.

📊 Technical Summary

PLUS THERAPEUTICS, INC. (PSTV) finished the session at 6.39 (+7.39%). Short-term positioning has improved with price above the 50-day average, although the chart still needs to reclaim the 200-day average to fully repair the bigger picture. 20-day momentum is positive at +6.50%; price is trading in the lower part of its roughly 52-week range (2.92–24.50); and ATR14 volatility is elevated at roughly 12.43% of price. RSI(14) reads 59.3, suggesting buyers still hold the momentum advantage. RSI has been trending higher in recent sessions, indicating improving momentum conditions. MACD is positioned above the signal line, supporting a still constructive momentum backdrop. The MACD histogram is positive and expanding, pointing to improving upside momentum. Recent trading volume is running below its typical 20-day average, which suggests participation remains relatively muted. Pattern signals currently detected: pat_hs. The most important nearby levels are support at 6.38 and resistance at 8.28. Clearing resistance would improve continuation odds, while slipping below support would weaken the present setup. On the fundamentals side, the latest snapshot shows Revenue: 1.40M · Net income: -4.42M · EPS (basic): -0.04. For a fuller technical read, the interactive view adds overlays, pattern context and broader chart structure.

Explore more